Safety and Efficacy of IONIS-FB-Lrx in up to 120 Patients 55 and Older With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Clinical trial NCT03446144 · WITHDRAWN
Trial details
- NCT number
- NCT03446144
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-16
- Primary completion
- 2018-10-10
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.